Does PALBOCICLIB Cause Thrombocytopenia? 1,328 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,328 reports of Thrombocytopenia have been filed in association with PALBOCICLIB (Ibrance). This represents 1.5% of all adverse event reports for PALBOCICLIB.
1,328
Reports of Thrombocytopenia with PALBOCICLIB
1.5%
of all PALBOCICLIB reports
169
Deaths
314
Hospitalizations
How Dangerous Is Thrombocytopenia From PALBOCICLIB?
Of the 1,328 reports, 169 (12.7%) resulted in death, 314 (23.6%) required hospitalization, and 93 (7.0%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which PALBOCICLIB Alternatives Have Lower Thrombocytopenia Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID